These observations, together with the clinicopathological features, illustrate that HSF2 is a newly identified multicancer-relevant gene with prognostic potential in cancer risk prediction and they support the possible effect of HSF2 on lymph node metastasis in COAD, ESCA, LIHC, LUSC, and STAD. This evidence concerns the gene HSF2 and cancer.